ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.90
-0.52 (-1.83%)
At close: May 15, 2026, 4:00 PM EDT
27.87
-0.03 (-0.11%)
After-hours: May 15, 2026, 4:10 PM EDT
ArriVent BioPharma Earnings Call Transcripts
Fiscal Year 2025
-
FV102 demonstrated significant protection against gluten-induced gut inflammation and symptoms in celiac disease, with a strong safety profile and plans for a larger phase 2 trial using composite histological and symptom endpoints.